{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:39:27Z","timestamp":1782837567818,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bioorg.2021.105068","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:19:33Z","timestamp":1623107973000},"page":"105068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis"],"prefix":"10.1016","volume":"114","author":[{"given":"Devendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Ranjan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Pathania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105068_b0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2021.105068_b0010","article-title":"Recent advancements in the development of heterocyclic anti-inflammatory agents","volume":"112438","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105068_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-57985-w","article-title":"Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells","volume":"10","author":"Steinmann","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.105068_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.1931.00150020080005","article-title":"Inflammation: a protective mechanism","volume":"48","author":"Menkin","year":"1931","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bioorg.2021.105068_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"2010","key":"10.1016\/j.bioorg.2021.105068_b0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2021.105068_b0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1600-065X.2000.17702.x","article-title":"Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses","volume":"177","author":"Chertov","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioorg.2021.105068_b0040","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.bioorg.2021.105068_b0045","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bioorg.2021.105068_b0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2021.105068_b0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1159\/000452591","article-title":"Triptolide attenuates inflammatory response in membranous glomerulo-nephritis rat via downregulation of NF-\u03baB signaling pathway","volume":"41","author":"Zhou","year":"2016","journal-title":"Kidney Blood Pressure Res."},{"key":"10.1016\/j.bioorg.2021.105068_b0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/09680519050110060301","article-title":"How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals","volume":"11","author":"Fritz","year":"2005","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.bioorg.2021.105068_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: A review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105068_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21242-z","article-title":"Arachidonic acid-regulated calcium signaling in T cells from patients with rheumatoid arthritis promotes synovial inflammation","volume":"12","author":"Ye","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2021.105068_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.archger.2003.10.001","article-title":"Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)\/cycloxigenase (COX) inhibition concept","volume":"38","author":"Gaddi","year":"2004","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.bioorg.2021.105068_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106190","article-title":"Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration","volume":"80","author":"Gao","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2021.105068_b0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","article-title":"A comprehensive review of the adverse effects of systemic corticosteroids","volume":"43","author":"Poetker","year":"2010","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.bioorg.2021.105068_b0090","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"346","author":"Day","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105068_b0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00044-018-02288-z","article-title":"Novel 2-(substituted phenyl Imino)-5-benzylidene-4-thiazolidinones as possible non-ulcerogenic tri-action drug candidates: synthesis, characterization, biological evaluation And docking studies","volume":"28","author":"Chawla","year":"2019","journal-title":"Med. Chem. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105068_b0100","first-page":"864","article-title":"Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies","volume":"21","author":"Kumar","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2021.105068_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd1034","article-title":"The development of COX2 inhibitors","volume":"2","author":"Flower","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.105068_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200363010-00003","article-title":"The second generation of COX-2 inhibitors","volume":"63","author":"Stichtenoth","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2021.105068_b0115","article-title":"Recent advancements in the development of bioactive pyrazoline derivatives","volume":"112666","author":"Nehra","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117631","article-title":"Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review","volume":"251","author":"Arora","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2021.105068_b0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/0929867003374219","article-title":"Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract","volume":"7","author":"Kirchrath","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2174\/138161207781368774","article-title":"Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks","volume":"13","author":"Martinez-Gonzalez","year":"2007","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.bioorg.2021.105068_b0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2021.105068_b0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejmech.2018.01.026","article-title":"Design, synthesis, biological evaluation and docking studies of new 3-(4, 5-dihydro-1H-pyrazol\/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors","volume":"145","author":"ElBordiny","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0145","unstructured":"J. Fort, Celecoxib, a COX-2--specific inhibitor: the clinical data, Am. J. Orthop. (Belle Mead, NJ) 28 (1999) 13-18."},{"key":"10.1016\/j.bioorg.2021.105068_b0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FPC.0b013e32834f94cb","article-title":"Celecoxib pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bioorg.2021.105068_b0155","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in medicinal chemistry","volume":"55","author":"Bostr\u00f6m","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bioorg.2016.11.014","article-title":"In vivo anti-inflammatory activity and docking study of newly synthesized benzimidazole derivatives bearing oxadiazole and morpholine rings","volume":"70","author":"Rathore","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2006.07.006","article-title":"Synthesis, characterization and in vitro antibacterial activity of new steroidal thiazolo quinoxalines","volume":"42","author":"Khan","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0170","first-page":"439","article-title":"Synthesis of some new 2-(3-methyl-7-substituted-2-oxoquinoxalinyl)-5-(aryl)-1, 3, 4-oxadiazoles as potential non-steroidal anti-inflammatory and analgesic agents","volume":"47","author":"Wagle","year":"2008","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0175","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmc.2007.11.014","article-title":"Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1, 3, 4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives","volume":"16","author":"Bhandari","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ardp.200800140","article-title":"Pyrazolo [3, 4-d] pyrimidine Derivatives as COX-2 Selective Inhibitors: Synthesis and Molecular Modelling Studies","volume":"342","author":"Raffa","year":"2009","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2021.105068_b0185","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.bmc.2014.03.043","article-title":"Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents","volume":"22","author":"Palkar","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0190","doi-asserted-by":"crossref","unstructured":"P.K. Singh, O. Silakari, Multitargeting Heterocycles: Improved and Rational Chemical Probes for Multifactorial Diseases, Key Heterocycle Cores for Designing Multitargeting Molecules, Elsevier2018, pp. 1-29.","DOI":"10.1016\/B978-0-08-102083-8.00001-7"},{"key":"10.1016\/j.bioorg.2021.105068_b0195","article-title":"Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?","volume":"1\u20134","author":"Pathania","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105068_b0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.bioorg.2021.105068_b0205","first-page":"223","article-title":"Studies on central nervous system depressants. (III). Influence of some tranquillizing agents on morphine analgesia","volume":"141","author":"Pc","year":"1963","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.bioorg.2021.105068_b0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1476-5381.1946.tb00045.x","article-title":"A method for the evaluation of analgesic activity using rats","volume":"1","author":"Davies","year":"1946","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.bioorg.2021.105068_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103497","article-title":"New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation","volume":"95","author":"Ahmed","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cbi.2018.03.013","article-title":"In vitro antioxidant activity of thiazolidinone derivatives of 1, 3-thiazole and 1, 3, 4-thiadiazole","volume":"286","author":"Djukic","year":"2018","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.bioorg.2021.105068_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103271","article-title":"Synthesis and biological evaluation of thiazolidine-2, 4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents","volume":"92","author":"Bansal","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2021.105068_b0235","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105068_b0240","unstructured":"L. Schr\u00f6dinger, QikProp, version 3.5, New York, NY (2012)."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821004454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821004454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:19:42Z","timestamp":1758615582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821004454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"alternative-id":["S0045206821004454"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105068","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105068"}}